Transcript Highlights:

• </c> purchase outpatient prescription purchase outpatient prescription medications<00:07:12.919><c> at
• </c><00:10:34.640><c> and</c> their ability to fill prescriptions and their ability to fill prescriptions
• We've written almost 5,000 prescriptions in fiscal 2024 at...
• We've written almost 5,000 prescriptions in fiscal 2024 at...
• </c> have provided over 4,500 prescriptions have provided over 4,500 prescriptions to<00:21:16.919><c

Keywords: 00:00 Introductions 02:46 Roll Call 03:35 Discussion on SB 14 46:13 Vote on SB 14 48:07 Discussion on SB 17 50:38 Vote on SB 17, 958, all

Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.

Transcript Highlights:

• I'm the executive director for the Missouri Prescription Drug Monitoring Program.
• And it's a pattern: the patient starts getting a prescription for Xanax.
• These patients, but these are not people who have prescriptive authority.
• They will not be checking for making a decision related to the prescription.
• Because any prescription is going to come back to you ultimately, right? Yes.

Keywords: 959, house, all

Transcript Highlights:

• You can take someone's property through acquisitive prescription.
• Prescription begins.” “Okay, so back to prescription.
• Prescription begins to run when?”
• The amendment tolls the filing prescriptive period.
• Is it a prescriptive period this five years?

Bills: HR217, HB66, HB204, HB208, HB326, HB472, HB483, HB484, HB793, HB1051, HB1080, HB1087, HB1111, HB1215, SB78, SB148

Keywords: rent stabilization, affordable housing, cost burdened, Louisiana housing, housing policy, emergency rental protections, Alexandria, municipal ordinances, administrative adjudication, code enforcement, housing violations, building codes, zoning, nuisance ordinances, vegetation ordinances, sewerage, drainage, licensing, permits, local government

Summary: The committee met on April 29 and considered a series of local and special bills affecting municipal and parish governance, blight enforcement, development districts, and term limits. Early action included a motion to apply a three-minute rule. House Bill 483, concerning the Fulberg/Marini Security and Improvement District in Orleans Parish, was voluntarily deferred after discussion and no support cards. House Bill 484, which revised the New Orleans Regional Business Park board by reducing membership from 12 to 11 and giving the mayor four direct appointments with removal authority, was adopted as a substitute and reported favorably. Senate Bill 78, dealing with the Shreveport Downtown Development District, was amended to correct a legislative district reference and then reported favorably. The committee also heard announcements that several previously deferred bills would not be heard that day. Several Shreveport-related blight bills were advanced. House Bill 1051, authorizing demolition of certain dilapidated properties in Shreveport, was amended to allow the city to rely on findings from code enforcement, fire, police, or other public safety officials, and then reported favorably. House Bill 1080, addressing condemned commercial property in Shreveport, was also reported favorably, though the author said he would continue consulting with the city attorney before floor consideration. House Bill 66 for Alexandria expanded the city’s administrative adjudication authority to cover a broader range of ordinance violations, including building, zoning, vegetation, nuisance, sewer, drainage, licensing, and permit matters; it was supported by the city and reported favorably. House Bill 326, requiring the Tickfaw police chief candidate to reside within the village, also passed favorably. House Bill 793, a contentious bill concerning recorded subdivision plats and prescription, drew extensive testimony from the author, parish officials, a former appellate judge, and the McCormick family. Supporters said the bill closes a loophole exposed by recent court rulings that could let noncompliant plats become enforceable after five years without actual notice to local governments, while opponents argued the current substitute still creates uncertainty and could burden property owners; the author said the bill was prospective only and would also go to the Law Institute. Despite the debate, the committee moved the substitute favorably. Senate Bill 148, allowing municipalities to pay a modest per diem to planning and zoning commission members by local ordinance, was reported favorably with support from Lake Charles. The committee rejected House Bill 208, which would have let St. Helena Parish voters decide whether to impose term limits on parish governing authority members. The bill’s author argued the people should decide, but the St. Helena Police Jury opposed it and committee members emphasized local control; the final vote was 3 yeas to 10 nays. House Bill 1215, concerning the disposition of historical statues and monuments, was amended to bar the Office of State Parks from placing transferred monuments back in the parish from which they were removed, and then was reported favorably. House Bill 472, authorizing local rent stabilization ordinances during a governor-declared emergency, was amended to limit such ordinances to the emergency period, tie increases to the consumer price index, and cap them at 365 days; discussion continued on whether the measure duplicated existing price-gouging laws and whether a broader study would be preferable.

Transcript Highlights:

• Yes, veterinarians can write prescriptions to individual people.
• </c><00:20:37.640><c> So,</c> prescriptions to individual people.
• So, prescriptions to individual people.
• And I understand I think prescription.
• prescription? prescription?

Keywords: 958, all

Summary: The committee first reviewed several Fish and Wildlife regulations. Staff explained amendments to 301 KAR 2:176, 4:112, and 6:030, including updating wildlife control tag language, creating an impoundment agent program for seized wildlife, and clarifying boating safety rules. A member raised a concern about boat wakes near docks, and staff said the commission had recently voted on related changes that were not yet included because the regulation had been filed earlier; those changes would have to come back later. The committee approved the staff amendments without objection. The Board of Veterinary Examiners then presented 201 KAR 16:767, which would require veterinary managers to be physically present during business hours and limit them to five registered facilities. Board representatives said they had tried to meet with affected parties before the hearing but had not reached agreement. A representative for Kentucky Pet IQ argued the rule was written for full-service hospitals and would be impractical for short, limited-service clinics that only provide vaccinations, preventive care, and parasite testing. Members expressed concern about the rule’s impact on veterinary access in underserved areas, and the committee voted to defer the regulation until the next month so the parties could continue negotiating. The committee next considered Transportation Cabinet 601 KAR 9:120, the online insurance verification system, in both ordinary and emergency form. The chair said staff had identified conflicts with a bill passed the prior year and moved to find the regulations deficient. The motion passed on a roll call vote, with six ayes and two pass votes. The committee then found ordinary ABC regulations 804 KAR 12:020 and 12:030 deficient as well, again by six ayes and two pass votes, after noting that the emergency versions had already been found deficient the previous month. Finally, the committee reviewed Cabinet for Health and Family Services 902 KAR 55:110, which would require veterinarians to report dispensed controlled substances to KASPER while exempting administered medications. OIG staff said the rule was meant to align regulation with statute, which includes veterinarians as prescribers, and emphasized that the reporting duty applies to prescriptions, not administration to animals. Some members supported the change as a needed anti-diversion measure, while others worried about implementation burdens and timing. After discussion, the committee found the regulation deficient by a 6-2 vote. The meeting then moved into full review of 922 KAR 1:565, a Department for Community Based Services rule implementing kinship care provisions from Senate Bill 151; staff said it was needed for implementation once funding is available, but a member criticized the two-year delay and the inclusion of language conditioning implementation on funding. A public witness from the Kinship Families Coalition argued the rule should not shift the 120-day application window in a way that could affect federal funding eligibility and urged the committee to reject the regulation as written.

Transcript Highlights:

• About a tenth goes to prescription drug spending.
• With prescription drugs, it's the same drug.
• drug spending has been... been, on average, prescription drug spending has been, or prescription drug
• We are expecting 2024 data any minute, but it does show prescription drugs, retail prescription drugs
• So I'm not here to say prescription drugs are bad.

Keywords: 1184, house, all

Transcript Highlights:

• </c><00:50:01.160><c> Drug</c> efficacy of the Prescription Drug efficacy of the Prescription Drug Affordability
• </c> to lowering the cost of prescription to lowering the cost of prescription drugs<00:50:14.000><c>
• </c> prescription drugs. prescription drugs.
• </c> affordable prescription drugs. affordable prescription drugs.
• </c> prescription drug. prescription drug.

Keywords: 981, all

Summary: The Senate met with a quorum, approved the journal, and then proceeded out of order to consider Senate Joint Resolution 20, recognizing April 9, 2026, as Home Education Day in Colorado. Senator Pelton spoke in strong support of home education, describing it as a parent-led choice that benefits students and families. The resolution was adopted on a 30-0 vote, and the current roll was added as co-sponsors. The chamber then took up the consent calendar and passed House Bill 1229, House Bill 1244, and Senate Bill 153. HB 1229, which concerns the human-animal bond as a social determinant of health, drew three no votes from Senators Pelton, Zamora Wilson, and Baeza; the other two measures passed unanimously. The Senate also laid over third reading of bills until Friday, April 10. In Committee of the Whole, senators considered Senate Bill 72, which increases criminal penalties for assaultive conduct involving a motor vehicle and adds causing death with a motor vehicle to criminally negligent homicide. The committee adopted the report and advanced the bill on second reading. Later, the chamber laid over Senate Bill 134 and House Bill 1084 until April 10, and then took up Senate Bill 140, which would exempt certain rare disease and plasma therapies from review by the Prescription Drug Affordability Review Board. Sponsors and supporters argued the bill protects access for patients with rare diseases and prevents harm to treatment development, while opponents said it would weaken the PDAB’s affordability work and was too broad. Senators Weisman and Gonzales spoke against the bill, with Weisman citing concerns about the federal definition used and Gonzales defending the PDAB’s role in lowering drug costs; the debate continued in the transcript without a final vote shown.

Transcript Highlights:

• they can quickly fill that prescription.
• the legwork of that caregiver with a written prescription in hand.
• My concerns are the narcotic versions of these prescriptions.
• When you get My concerns are the narcotic versions of these prescriptions.
• So then you can transfer the prescription by law. How many times? One.

Summary: The subcommittee met with a quorum present and took up five health-related bills. HB 1089, which would add Duchenne muscular dystrophy to Florida’s newborn screening panel, was presented as a way to enable earlier diagnosis and treatment; a pediatric neurologist from Nemours testified in support, noting existing FDA-approved therapies and ongoing clinical trials. After supportive debate, the bill passed 17-0 and was reported favorably. HB 1083 would standardize patient access to medical records by setting deadlines for providers to produce or allow inspection of records and requiring electronic delivery when available. Supporters said it would reduce delays in care and costs, while two industry groups appeared in opposition. Members from both parties spoke in favor, and the bill passed 17-0 and was reported favorably. HB 1297, which aligns Florida’s electronic prescribing rules more closely with federal law and removes some state exceptions, drew opposition from physicians who argued paper prescriptions are still needed for emergencies, shortages, and price shopping. The sponsor said the bill’s goals were patient safety, fraud prevention, and efficiency; despite concerns, it passed 18-0 and was reported favorably. The committee then considered PCS for HB 1421, the Emily Adkins Family Protection Act, which would create a statewide blood clot and pulmonary embolism registry, require hospital reporting and risk-assessment policies, and expand training requirements in hospitals, nursing homes, and assisted living facilities. The bill was presented with emotional testimony from Emily Adkins’ parents, who urged support and co-sponsorship in her memory. Members from both parties praised the family’s advocacy, and the PCS passed 18-0 and was reported favorably. Finally, HB 449 on optometry would expand optometrists’ authority to prescribe certain medications and perform specified laser and non-laser eye procedures after certification. The bill and amendment drew strong opposition from ophthalmologists and their association, who raised patient-safety, training, and delegation concerns, while optometrists argued the bill would improve access, especially in rural areas and counties without ophthalmologists. The amendment was adopted, and the bill as amended passed on a recorded vote and was reported favorably.

Transcript Highlights:

• prescriptions after they file the 12 monthly prescriptions from the same medical practice.
• Monthly prescriptions can be more expensive than quarterly prescriptions, and the time spent for the
• </c> supply provided that a prescription supply provided that a prescription includes<01:02:35.880><c
• </c><01:02:43.440><c> from</c> previously filled 12 prescriptions from previously filled 12 prescriptions
• </c> to just have a quarterly prescription to just have a quarterly prescription from<01:05:43.279><c

Keywords: 1191, senate, all

Transcript Highlights:

• </c> Did Medicaid pay for any prescription Did Medicaid pay for any prescription drug<00:05:59.600><c
• > weight</c> diabetes and prescriptions for weight diabetes and prescriptions for weight loss.<00:10:
• </c><00:10:31.120><c> loss</c> prescriptions approved for weight loss prescriptions approved for weight
• prescription was $975. prescription was $975.
• </c> prescription is $109. prescription is $109.

Keywords: 958, all

Summary: The Medicaid Oversight and Advisory Board met on February 23, 2026, approved the January 12 minutes, and then focused primarily on Kentucky Medicaid’s coverage and potential expansion of GLP-1 drugs, especially for weight loss. Department for Medicaid Services Commissioner Lisa Lee explained that Medicaid currently does not cover drugs for weight loss, anorexia, or weight gain, but the department had filed a regulation to remove that blanket exclusion so GLP-1s could be covered when used for an underlying health condition. She said the administrative regulation review subcommittee found the regulation deficient, and the co-chairs wanted the board to discuss the policy and financing implications before any change. DMS also said it would be open to adding caveats to ensure coverage would not extend to cosmetic weight loss alone. The department provided several data points on current utilization and spending. In 2025, Kentucky Medicaid paid for appetite-stimulating drugs such as Megestrol, Dronabinol, and Marinol, but did not pay for weight-loss drugs. For GLP-1s, DMS said coverage began in 2025 and is limited to FDA-approved medical conditions, with prior authorization requiring a type 2 diabetes diagnosis code and A1C documentation. DMS reported $234.6 million in GLP-1 spending in 2025 before rebates, about 240,931 prescriptions, and said GLP-1s accounted for 7.3% of pharmacy spend in 2024 and 8.3% in 2025. It also said there were 24,844 expansion members and 13,638 non-expansion members using GLP-1s, with spending of about $156 million and $78.5 million respectively, and that 10 pediatric weight-loss prescriptions were covered under EPSDT. The department said outcome analyses, including whether GLP-1 use reduces insulin or other diabetes treatment, are underway and should be completed in a couple of months. Members asked about cost, rebates, and whether the state should wait for more outcomes data before expanding coverage. DMS said average reimbursement to pharmacies was $975 per prescription and the average dispensing fee was $109; it also said 2025 rebate invoices totaled $90.8 million, with $7.6 million collected so far. Several members expressed concern about the high cost and the need to evaluate whether the drugs improve health outcomes before expanding access, while others noted the potential benefits for obesity and diabetes treatment. Some members also discussed whether GLP-1s are effectively being used for weight loss in diabetic patients and whether broader data collection should be used to assess long-term value. After the Medicaid discussion, Eli Lilly executive Tracy Sims presented on obesity as a chronic disease and the economic burden it creates in Kentucky. She said Kentucky’s adult obesity rate is a little over 37%, that obesity is linked to about 200 diseases, and that untreated obesity costs the state billions in GDP and hundreds of millions in state budget impact. She highlighted recent federal access programs for GLP-1s, including a Medicaid-related program that she said could lower the state share of a Zepbound prescription to about $71 per month after federal matching. No votes were taken on the GLP-1 policy question during the meeting, and the main action was the receipt of testimony and discussion of the department’s proposed regulatory change.

Transcript Highlights:

• So how does Senate Bill 316 help Nevada save money on prescription drugs?
• counter when they were paying for their prescriptions.
• In the United States, nine out of 10 prescriptions filled are for generic drugs.
• So it allows you to use your prescription, your pharmacy. Thank you.
• So it allows you to use your prescription, your pharmacy. Thank you so much.

Bills: AB93, AB204, AB414, AB504, AB598

Keywords: public employees, police officers, benefits, appropriation, law enforcement, medical debt, collection agency, healthcare, consumer protection, financial assistance, occupational safety, air quality, greenhouse gases, employee monitoring, safety program, hemp, hemp products, cannabidiol, CBD, cannabis

Transcript Highlights:

• Second, let's make sure that our state prescription monitoring program can't be used by the...
• The prescription monitoring program was established to prevent abuse of prescription drugs, especially
• He obtained information from the Texas Prescription Monitoring Program about prescriptions for gender-affirming
• I have heard this from so many people, so many providers... ...the prescription monitoring program.
• , right, receiving those prescriptions.

Keywords: 995, all

Summary: The Senate Committee on Steering and Policy held a public hearing on potential updates to Massachusetts’ 2022 Shield Law to strengthen protections for reproductive and gender-affirming health care. Chair Cindy Friedman said the hearing was prompted by escalating federal and out-of-state threats, and testimony was sought on loopholes and clarifications involving emergency abortion care, limits on cooperation with outside investigations, protection of patient data, and safeguarding licenses of providers and attorneys involved in this care. The Attorney General’s Office, ACLU of Massachusetts, GLBTQ Legal Advocates and Defenders, Reproductive Equity Now, the Massachusetts Medical Society, TransHealth, and Health Imperatives all supported strengthening the law. Witnesses urged broader bans on sharing health data with hostile states, explicit AG enforcement authority, exclusion of reproductive and gender-affirming prescriptions from the prescription monitoring program, protections for electronic medical records, and allowing clinicians to use practice names on prescription labels. Several speakers also called for protections for parents of transgender youth, attorneys, and nonprofit organizations, and some raised related concerns about insurance discrimination and the burden of post-24-week abortion restrictions. Committee members asked questions about enforcement mechanisms, data privacy, patient consent, and how to balance interoperability with privacy protections in electronic records. Witnesses said the goal was to prevent immediate harm while preserving patient control and access to care. No votes were taken during the hearing, and the chair closed by inviting written testimony and then moved to adjourn the hearing.

Transcript Highlights:

• Kincart Jonsson: THANK YOU GOOD AFTERNOON , THANK YOU FOR ALLOWING ME TO PRESENT HB 697, THE PRESCRIPTION
• THE US BUYS 23% OF THE WORLDS PRESCRIPTION DRUGS BUT PAYS 62% OF THE WORLDWIDE COST.
• ACROSS FLORIDA FAMILIES ARE VIEWING THE STRAIN OF RISING PRESCRIPTION DRUG COSTS, THE PRICE ACT IS FOCUSED
• GENERICS MAKE UP 90% OF PRESCRIPTIONS PRESCRIBED WOULD ONLY REPRESENT 15 TO 20% OF SALES. 10% REALLY
• THE PRESCRIPTION DRUG SYSTEM OPERATES SORT OF LIKE THE MAFIA.

Transcript Highlights:

• This instrument provides relative to a prescription drug... ...by Senator Talbot.
• It's just really a report on the status of important prescription drugs in our state.
• We're really looking at more common, everyday prescription drugs that are more common.
• About the high cost of prescription drugs and what it is that can be done.
• You heard about the Prescription Drug Affordability Board.

Keywords: 965, house, all

Transcript Highlights:

• the Vermont prescription drug discount card program, affecting the revenue of the state.
• In section six amends the eligibility requirements for VARMM, a prescription drug assistance program.
• In section six amends the eligibility requirements for VARMM, a prescription drug assistance program.
• In section six amends the eligibility requirements for VARMM, a prescription drug assistance program.
• prescription drugs for which the price prescription drugs for which the price has<00:14:49.120><c> recently

Keywords: 926, house, all

Summary: The House opened with a devotional by Reverend Kemp Randolph, who reflected on the idea that simpler solutions often require letting go of existing assumptions and urged lawmakers to consider what they may need to give up to achieve the greatest good. After the prayer, the chamber introduced House Bill 889, exempting disability-related income on candidate disclosure forms, and House Bill 890, aimed at reducing barriers for nonprofit religious organizations providing preventive health care services. Both bills were read the first time and referred to committee. The House also referred three bills to money committees under House Rule 35A: H.548 to Appropriations, and H.557 and H.567 to Ways and Means. Members then offered several announcements, including welcoming the guest pastor Kemp Randolph and visiting European Parliament member Maria Walsh, along with her mother and aunt. There were also notices about caucus meetings and a correction to a prior vote explanation regarding H.70. The House then took up H.611, a technical and housekeeping bill affecting the Department of Vermont Health Access. Committee testimony and floor remarks described provisions to reduce administrative burdens, update advisory committee membership, remove outdated references tied to the individual/small group market split, adjust the VARMM prescription drug assistance program, increase the allowable amount in Medicaid-related prepaid funeral arrangements, and delay Medicaid coverage for doula services by one year while federal approval is sought. The Health Care and Appropriations committees both recommended the bill, with Appropriations noting no fiscal impact and correcting a prior vote tally. The House adopted the Health Care Committee amendment to H.611 and ordered the bill to third reading. It then passed H.540, relating to recommendations of the post-adjudication reparative program working group. Finally, the House concurred in the Senate proposal of amendment with further amendment on H.50, concerning identification of underutilized state buildings and land; the committee explained changes restoring annual reporting, removing leased buildings from the inventory, and directing annual reports to the Department of Housing and Community Development through 2030. The chamber concluded with announcements about a Joint Fiscal Committee meeting on a rural health transformation grant and then adjourned until February 10, 2026.

Transcript Highlights:

• It's available now by prescription.
• And that label is on the prescription form of the drug.
• So when I go to get a prescription, because I obviously can't get prescriptions.
• That's part of our prescriptive authority.
• You can order a prescription. In India, it's not prescription.

Bills: HB 265, HB25

Keywords: youth camp, safety regulations, advisory committee, child welfare, health standards, summer camp, camp safety, child abuse reporting, child neglect, mandatory reporting, background check, criminal history check, sex offender registry, CPR training, first aid, public health, child protection, camp operator, camp counselor, Health and Safety Code

Transcript Highlights:

• And that throughout the past 20 years, prescription.
• I'm only on one prescription med.
• I'm only on one prescription med.
• If 100% of it was passed on to the patient, would be for three prescriptions, $5, and for six prescriptions
• On your first eight prescriptions of the day, and you're down $400 after you've filled eight prescriptions

Bills: SB206, SB640, SB667, SB1344, SB1380, SB1423, SB1425, SB1436, SB1484, SB1500, SB1502, SB1503, SB1557, SB1562, SB1572, SB1644, SB1645, SB1794, SB1796, SB1806, SB1849, SB1984, SB2007, SB2074

Keywords: SB206, emergency medical services, EMS, ambulance, 911 response, emergency response, essential services, federal funding, grant funding, public health, health care facility, municipality, county, ambulance service district, tribal entity, public entity, contract ambulance service, Oklahoma, 63 O.S. 2021 Section 1-2502, emergency clause

Summary: The committee opened with prayer and then took up a series of health and human services bills, most of them moving forward on do-pass motions. Senate Bill 1645 would set audit procedures for Medicaid providers, with discussion focused on protecting providers from penalties for scrivener’s or typographical errors while still holding them accountable for fraud or failure to provide services. Senate Bills 1796 and 1806 addressed foster care, including a 72-hour cap on informal care and extending foster care to age 21 for youth continuing their education. Senate Bills 1423, 1425, and 1502 all repealed outdated advisory councils or programs that were no longer active or needed. SB 206, as amended, expanded licensed ambulance services as essential services to help them access more federal funding, and SB 500 sought to prevent pharmacy benefit managers from delaying payments to pharmacists. These measures were reported out with unanimous or near-unanimous votes. The committee also heard Senate Bill 1503, which would allow certain nonprofit pregnancy-support organizations without an Oklahoma physical address to apply for Choosing Childbirth grants. Members questioned whether state dollars could go to out-of-state personnel and how telehealth and reporting requirements would work. The bill was laid over for further amendment work. Senate Bill 1557 would place certified behavioral analysts under the State Board of Examiners of Psychology, and members raised questions about how it might interact with a separate bill affecting board authority; it passed after discussion. Senate Bill 1894 gave the podiatry board authority over continuing education, and SB 1984 was a cleanup bill for the Board of Osteopathic Medicine, including authority over certain licensure and telemedicine-related review issues; both passed after questions about scope and reciprocity. Later, the committee considered several pharmacy and insurance-related bills. SB 1344 created an insulin access and affordability program to partner with manufacturers of low-cost biosimilar insulin, and SB 1380 required Medicaid eligibility checks against death records, with an amendment discussed to protect long-term care facilities from retroactive nonpayment when eligibility is delayed. SB 1572 would commission a feasibility study on dissolving the Department of Mental Health and temporarily allow the Health Care Authority commissioner to oversee both agencies. SB 2007 required PBMs to reimburse pharmacists at actual acquisition cost when reimbursement falls below cost, with escalating fines for noncompliance. SB 2074 would impose a mandatory dispensing fee tied to the Medicaid rate; it drew extensive debate over whether costs would be shifted to employers, employees, or the state, and over the impact on pharmacy closures and rural access. The committee ultimately reported the bills out, with SB 2074 passing after lengthy discussion and a final vote.

Transcript Highlights:

• </c> prescription form formula. prescription form formula.
• </c> So, if I were to get a prescription So, if I were to get a prescription today<03:47:22.560><c> for
• </c> actual drug that's a prescription drug. actual drug that's a prescription drug.
• </c><03:57:22.239><c> I</c> do is allow as you said a prescription I do is allow as you said a prescription
• </c><03:57:40.640><c> equivalent</c> excuse me prescription equivalent excuse me prescription equivalent

Keywords: 1189, house, all

Transcript Highlights:

• This is a very real problem that people who have prescriptions are unable to get their prescriptions
• It's three prescriptions.
• We also need to discuss why there's a prescription drug monitoring system.
• So, for instance, if there's a 30-day supply plus three additional prescriptions, different prescriptions
• And the three extra prescriptions, just to clarify, are three two-week prescriptions at 24 milligrams

Transcript Highlights:

• Despite comprising only 5% of all prescriptions, biologics account for over half of all drug spending
• It also allows health plans to require patients Substitute in the prescription.
• Is it any time it gets renewed, or is it only the initial prescription? Yeah.
• No, anytime you write a prescription, you can always put “do not substitute.”
• So when you do that, does the insurance company have to okay your prescription? Yes. In 30 days?

Summary: The Senate Business, Professions and Economic Development Committee heard SB 1094 by Senator Weber Pierson, which would expand pharmacist substitution authority for biosimilars and allow health plans to require use of lower-cost generic or biosimilar alternatives when available, unless the prescriber marks “do not substitute.” The author said the bill is intended to lower prescription drug costs, improve access, and require insurers to report on whether substitutions reduce out-of-pocket costs and premium growth. Committee amendments were accepted, including changes to align definitions with federal law, require a link to the FDA Purple Book, add a 30-day advance notice requirement for plan-driven substitutions, and allow exceptions for patients or providers. Supporters included Blue Shield of California, Sharp HealthCare, health plans, CVS, the California Chamber of Commerce, and other business and health care groups, who argued the bill would increase competition, reduce costs, and remove administrative barriers to using FDA-approved biosimilars. Opponents and “opposed unless amended” witnesses, including the Biotechnology Innovation Organization, the California Rheumatology Alliance, and some physician groups, argued the bill goes beyond current FDA interchangeability standards, could undermine physician judgment, and may create patient safety concerns for some chronic-disease patients who react differently to biosimilars or experience problems with multiple switches. Committee members discussed the “do not substitute” option, patient notification, insurance approval, and whether the bill preserves physician discretion. After debate, Senator Arreguín moved the bill, and the committee voted 10-0 to pass SB 1094 as amended to the Senate Health Committee.

Transcript Highlights:

• Uh, prescription in order to access it.
• Does the prescription need to change?
• So when I go to get a prescription, uh, because I obviously can't get prescription medicine myself, I
• You can order prescription drugs in the mail. In India it's not prescription.
• To have without a prescription.

Bills: HB 265, HB25

Keywords: youth camp, safety regulations, advisory committee, child welfare, health standards, summer camp, camp safety, child abuse reporting, child neglect, mandatory reporting, background check, criminal history check, sex offender registry, CPR training, first aid, public health, child protection, camp operator, camp counselor, Health and Safety Code